ROME Therapeutics Funding: $199M Raised, Series B (2023)
ROME Therapeutics is a Biotech company based in Boston, Massachusetts. It has raised $199M in total funding. Latest round: Series B.
ROME Therapeutics funding overview
ROME Therapeutics is a Biotech company based in Boston, Massachusetts. ROME Therapeutics has raised $199M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for ROME Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Alexandria Venture Investments, Andreessen Horowitz, Bristol Myers Squibb, Casdin Capital, Eurofarma Ventures, GV and 8 others. 14 distinct backers are named across the disclosed rounds.
ROME Therapeutics at a glance
Total raised
$199M
Latest round
Series B
Latest round date
September 2023
Industry
Biotech
Headquarters
Boston, Massachusetts
Notable investors
Alexandria Venture Investments, Andreessen Horowitz, Bristol Myers Squibb, Casdin Capital, Eurofarma Ventures, GV, Johnson & Johnson Innovation, Luma Group
Frequently asked about ROME Therapeutics funding
How much has ROME Therapeutics raised?
ROME Therapeutics has raised $199M in total disclosed funding across the rounds on record.
Who has invested in ROME Therapeutics?
Alexandria Venture Investments, Andreessen Horowitz, Bristol Myers Squibb, Casdin Capital, Eurofarma Ventures, GV are named among the investors backing ROME Therapeutics.
What was the latest ROME Therapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2023.
Where is ROME Therapeutics based?
ROME Therapeutics is based in Boston, Massachusetts.
What sector does ROME Therapeutics operate in?
ROME Therapeutics is tracked under Biotech from Boston, Massachusetts, with $199M in disclosed funding.
When did ROME Therapeutics last raise?
The last disclosed ROME Therapeutics round closed in September 2023 at Series B.
We update the ROME Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.
